Post-stroke Delirium in Ischemic Stroke Patients

Sponsor
Jinan University Guangzhou (Other)
Overall Status
Completed
CT.gov ID
NCT06005636
Collaborator
First Affiliated Hospital of Jinan University (Other)
985
1
19.8
49.7

Study Details

Study Description

Brief Summary

This study is to investigate the predictors of post-stroke delirium, develop and validate a nomogram of post-stroke delirium in the ischemic stroke patients.

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: Test delirium state

Detailed Description

Introduction: Post-stroke delirium (PSD) is associated with unfavorable prognosis. Effectively identifying risk factors of PSD and predicting PSD is of essential.

Methods: This is a prospective, single-centered, cohort study.

Study Design

Study Type:
Observational
Actual Enrollment :
985 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Risk Factors and Risk Prediction Model for Post-stroke Delirium in Ischemic Stroke Patients
Actual Study Start Date :
Sep 1, 2021
Actual Primary Completion Date :
Sep 10, 2022
Actual Study Completion Date :
Apr 27, 2023

Arms and Interventions

Arm Intervention/Treatment
with post-stroke delirium

ischemic stroke patients with post-stroke delirium

Diagnostic Test: Test delirium state
use scale to test whether ischemic stroke patients have post-stroke delirium

without post-stroke delirium

ischemic stroke patients without post-stroke delirium

Diagnostic Test: Test delirium state
use scale to test whether ischemic stroke patients have post-stroke delirium

Outcome Measures

Primary Outcome Measures

  1. post-stroke delirium [The first week of admission]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 100 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. aged ≥18 years old;(2) ischemic stroke, confirmed by computed tomography (CT) or magnetic resonance imaging (MRI) scans;(3) patients or their agencies agree to participate in this study.
Exclusion Criteria:
  1. brain dysfunction caused by non-vascular causes such as traumatic brain injury, brain tumor or metastatic brain tumor;(2) history of serious mental illness such as schizophrenia;(3) unable to cooperate to the assessment as deafness, blindness, aphasia, dysarthria;(4) be in coma [Glasgow Coma Scale (GCS)≤8 points] or sedation [Richmond Agitation Sedation Scale (RASS)<-3 points], and do not ameliorate during study;(5) with incomplete data.

Contacts and Locations

Locations

Site City State Country Postal Code
1 the First Affiliated Hospital of Jinan University Guangzhou Guangdong China 510630

Sponsors and Collaborators

  • Jinan University Guangzhou
  • First Affiliated Hospital of Jinan University

Investigators

  • Principal Investigator: Fengxia Yan, Jinan University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Xiaoyan Cai, Ms, Jinan University Guangzhou
ClinicalTrials.gov Identifier:
NCT06005636
Other Study ID Numbers:
  • KY-2021-106
First Posted:
Aug 22, 2023
Last Update Posted:
Aug 22, 2023
Last Verified:
Aug 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 22, 2023